Havers W - Search Results

1

Prediction of clinical outcome and biological characterization of neuroblastoma by expression profiling.

Schramm A, Schulte JH, Klein-Hitpass L, Havers W, Sieverts H, Berwanger B, Christiansen H, Warnat P, Brors B, Eils J, Eils R, Eggert A. Schramm A, et al. Among authors: havers w. Oncogene. 2005 Nov 24;24(53):7902-12. doi: 10.1038/sj.onc.1208936. Oncogene. 2005. PMID: 16103881

2

High activin A-expression in human neuroblastoma: suppression of malignant potential and correlation with favourable clinical outcome.

Schramm A, von Schuetz V, Christiansen H, Havers W, Papoutsi M, Wilting J, Schweigerer L. Schramm A, et al. Among authors: havers w. Oncogene. 2005 Jan 20;24(4):680-7. doi: 10.1038/sj.onc.1208087. Oncogene. 2005. PMID: 15580313

3

Microarray analysis reveals differential gene expression patterns and regulation of single target genes contributing to the opposing phenotype of TrkA- and TrkB-expressing neuroblastomas.

Schulte JH, Schramm A, Klein-Hitpass L, Klenk M, Wessels H, Hauffa BP, Eils J, Eils R, Brodeur GM, Schweigerer L, Havers W, Eggert A. Schulte JH, et al. Among authors: havers w. Oncogene. 2005 Jan 6;24(1):165-77. doi: 10.1038/sj.onc.1208000. Oncogene. 2005. PMID: 15637590

4

Microarray-analysis: a new approach to study the molecular mechanisms of thermo-chemotherapy.

Schulte JH, Schramm A, Pressel T, Klein-Hitpass L, Kremens B, Eils J, Havers W, Eggert A. Schulte JH, et al. Among authors: havers w. Klin Padiatr. 2003 Nov-Dec;215(6):298-302. doi: 10.1055/s-2003-45501. Klin Padiatr. 2003. PMID: 14677092

5

Proteomics: techniques and applications in cancer research.

Schramm A, Apostolov O, Sitek B, Pfeiffer K, Stühler K, Meyer HE, Havers W, Eggert A. Schramm A, et al. Among authors: havers w. Klin Padiatr. 2003 Nov-Dec;215(6):293-7. doi: 10.1055/s-2003-45502. Klin Padiatr. 2003. PMID: 14677091

6

Hypoxia promotes apoptosis of human neuroblastoma cell lines with enhanced N-myc expression.

Rössler J, Schwab M, Havers W, Schweigerer L. Rössler J, et al. Among authors: havers w. Biochem Biophys Res Commun. 2001 Feb 23;281(2):272-6. doi: 10.1006/bbrc.2001.4342. Biochem Biophys Res Commun. 2001. PMID: 11181040

7

Vascular endothelial growth factor expression in human neuroblastoma: up-regulation by hypoxia.

Rössler J, Breit S, Havers W, Schweigerer L. Rössler J, et al. Among authors: havers w. Int J Cancer. 1999 Mar 31;81(1):113-7. doi: 10.1002/(sici)1097-0215(19990331)81:1<113::aid-ijc19>3.0.co;2-l. Int J Cancer. 1999. PMID: 10077161 Free article.

8

Hypoxia-induced erythropoietin expression in human neuroblastoma requires a methylation free HIF-1 binding site.

Rössler J, Stolze I, Frede S, Freitag P, Schweigerer L, Havers W, Fandrey J. Rössler J, et al. Among authors: havers w. J Cell Biochem. 2004 Sep 1;93(1):153-61. doi: 10.1002/jcb.20133. J Cell Biochem. 2004. PMID: 15352172

9

Arginine deiminase and other antiangiogenic agents inhibit unfavorable neuroblastoma growth: potentiation by irradiation.

Gong H, Pöttgen C, Stüben G, Havers W, Stuschke M, Schweigerer L. Gong H, et al. Among authors: havers w. Int J Cancer. 2003 Sep 20;106(5):723-8. doi: 10.1002/ijc.11298. Int J Cancer. 2003. PMID: 12866032 Free article.

10

Postoperative radiotherapy of spinal and intracranial ependymomas: analysis of prognostic factors.

Stüben G, Stuschke M, Kroll M, Havers W, Sack H. Stüben G, et al. Among authors: havers w. Radiother Oncol. 1997 Oct;45(1):3-10. doi: 10.1016/s0167-8140(97)00138-2. Radiother Oncol. 1997. PMID: 9364625 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

86 results

Search Page